"Oncolytic Virotherapy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Use of attenuated VIRUSES as ANTINEOPLASTIC AGENTS to selectively kill CANCER cells.
| Descriptor ID |
D050130
|
| MeSH Number(s) |
E02.095.601
|
| Concept/Terms |
Oncolytic Virotherapy- Oncolytic Virotherapy
- Oncolytic Virotherapies
- Virotherapies, Oncolytic
- Virotherapy, Oncolytic
- Oncolytic Virus Therapy
- Oncolytic Virus Therapies
- Therapies, Oncolytic Virus
- Therapy, Oncolytic Virus
- Virus Therapies, Oncolytic
- Virus Therapy, Oncolytic
|
Below are MeSH descriptors whose meaning is more general than "Oncolytic Virotherapy".
Below are MeSH descriptors whose meaning is more specific than "Oncolytic Virotherapy".
This graph shows the total number of publications written about "Oncolytic Virotherapy" by people in this website by year, and whether "Oncolytic Virotherapy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 3 | 3 | 6 |
| 2018 | 5 | 1 | 6 |
| 2019 | 4 | 2 | 6 |
To return to the timeline, click here.
Below are the most recent publications written about "Oncolytic Virotherapy" by people in Profiles.
-
Genetic and Chemical Capsid Modifications of Adenovirus Vectors to Modulate Vector-Host Interactions. Viruses. 2021 07 02; 13(7).
-
Membrane cofactor protein (MCP; CD46): deficiency states and pathogen connections. Curr Opin Immunol. 2021 10; 72:126-134.
-
Oncolytic viral immunotherapy in the time of COVID-19. Cytokine Growth Factor Rev. 2020 12; 56:1-3.
-
The lytic activity of VSV-GP treatment dominates the therapeutic effects in a syngeneic model of lung cancer. Br J Cancer. 2019 10; 121(8):647-658.
-
Xenoantigen-Dependent Complement-Mediated Neutralization of Lymphocytic Choriomeningitis Virus Glycoprotein-Pseudotyped Vesicular Stomatitis Virus in Human Serum. J Virol. 2019 09 15; 93(18).
-
A clinical trial investigating biodistribution and shedding of an oncolytic virus. EBioMedicine. 2019 09; 47:4-5.
-
Induced Vitiligo due to Talimogene Laherparepvec Injection for Metastatic Melanoma Associated with Long-term Complete Response. Acta Derm Venereol. 2019 Feb 01; 99(2):232-233.
-
Novel Immunotherapeutics for Treatment of Glioblastoma: The Last Decade of Research. Cancer Invest. 2019; 37(1):1-7.
-
Pricing a Year of Progression-Free Survival: When Is the Cost of Cancer Drugs Unreasonable? JAMA Dermatol. 2019 01 01; 155(1):15-16.
-
A Novel Chimeric Oncolytic Virus Vector for Improved Safety and Efficacy as a Platform for the Treatment of Hepatocellular Carcinoma. J Virol. 2018 12 01; 92(23).